Creating a vaccine to protect against coronaviruses
Official title: DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES
Funded at Icahn School of Medicine at Mount Sinai · NIH-10912982 · Data updated 2026-11-12
This study is working on a new vaccine to help protect against coronaviruses, which cause illnesses like COVID-19, so that we can be better prepared for any future outbreaks and keep people safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $15,898,493 |
| NIH project number | 75N93023C00019-0-9999-1 |
| Project ID | NIH-10912982 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of exposure to coronaviruses, including healthcare workers and those in close contact with infected individuals.
✕Less likely to help
Patients who are not at risk of exposure to coronaviruses or those who have already been vaccinated against them may not receive benefit from this research.
What this research studies
This research focuses on developing a vaccine candidate specifically targeting coronaviruses, which are responsible for various infectious diseases. The approach includes formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through nonclinical studies in animal models. The ultimate goal is to prepare for potential outbreaks by ensuring the vaccine is ready for clinical trials and regulatory approval. Patients may benefit from this research as it aims to provide a preventive measure against future coronavirus outbreaks.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that protects patients from severe illnesses caused by coronaviruses.
How similar studies have gone: Previous research on vaccine development for coronaviruses has shown promise, particularly in the context of the COVID-19 pandemic, indicating that this approach is both relevant and potentially effective.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genetically Validated PCOS Subtypes for Better Diagnosis and Risk Stratification
Aimed at women with polycystic ovary syndrome (PCOS), this project uses genetic data and patient characteristics to define distinct PCOS subtypes and improve how we diagnose and estimate risk.
-
Closed-loop control of interneuron timing to influence seizures and memory in epilepsy
A study tests a brain-quieting system that uses light to precisely time certain brain cells in epilepsy-prone mice to see if this can lessen seizures and improve memory.
-
Understanding why some brain regions and cells accumulate tau in Alzheimer’s and related diseases
Researchers are studying why certain brain areas and neuron types accumulate tau protein in Alzheimer’s and related conditions, and how this leads to brain changes and symptoms.
-
Improving blood flow after stroke by breaking down NETs
Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.
-
Aging and brain injury connection: learning how late-life TBI relates to Alzheimer’s and related dementias
This grant looks at whether traumatic brain injuries in people 65 and older are linked to Alzheimer’s disease and related dementias, using a large, harmonized set of long-term aging studies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.